You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 29, 2026

Details for New Drug Application (NDA): 209170

✉ Email this page to a colleague

« Back to Dashboard

NDA 209170 describes DESOGESTREL AND ETHINYL ESTRADIOL, which is a drug marketed by Duramed Pharms Barr, Dr Reddys Labs Sa, Naari Pte, Novast Labs, Watson Labs, and Xiromed, and is included in nine NDAs. It is available from seven suppliers. Additional details are available on the DESOGESTREL AND ETHINYL ESTRADIOL profile page.

The generic ingredient in DESOGESTREL AND ETHINYL ESTRADIOL is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

Summary for 209170

Tradename:	DESOGESTREL AND ETHINYL ESTRADIOL
Applicant:	Naari Pte
Ingredient:	desogestrel; ethinyl estradiol
Patents:	0

Suppliers and Packaging for NDA: 209170

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DESOGESTREL AND ETHINYL ESTRADIOL	desogestrel; ethinyl estradiol	TABLET;ORAL-28	209170	ANDA	Naari Pte. Limited	79929-020	79929-020-07	3 BLISTER PACK in 1 POUCH (79929-020-07) / 1 KIT in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL-28			Strength	0.15MG,N/A;0.02MG,0.01MG
Approval Date:	Jun 5, 2017	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.